0001837999-21-000001.txt : 20211119 0001837999-21-000001.hdr.sgml : 20211119 20211119094909 ACCESSION NUMBER: 0001837999-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 EFFECTIVENESS DATE: 20211119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMvention Therapeutix, Inc. CENTRAL INDEX KEY: 0001837999 IRS NUMBER: 822411198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-384379 FILM NUMBER: 211426730 BUSINESS ADDRESS: STREET 1: 701 W. MAIN STREET STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-593-6230 MAIL ADDRESS: STREET 1: 701 W. MAIN STREET STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D/A 1 primary_doc.xml X0708 D/A LIVE 0001837999 IMMvention Therapeutix, Inc. 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 919-593-6230 DELAWARE None None Corporation true 2017 Anil Goyal 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Executive Officer Director Matthew Cohen 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Director Benjamin Scruggs 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Director Jenny Ting 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Director Lev Osherovich 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Director Mark Vellaca 9 Laboratory Drive Suite 264 RTP NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b true 0001837999-20-000001 2020-12-07 true true false 0 6899999 6899999 0 false 5 0 0 0 true false IMMvention Therapeutix, Inc. Anil Goyal Anil Goyal CEO 2021-11-19